Cargando…

Patient‐reported outcomes following autologous stem cell transplant for patients with multiple myeloma

We evaluated changes in patient‐reported outcomes and cognitive function from pre‐ to 3–6 months post‐treatment among 42 newly diagnosed patients with multiple myeloma undergoing transplant with complete data using PROMIS‐29. There were statistically significant improvements in physical (p < .001...

Descripción completa

Detalles Bibliográficos
Autores principales: Biran, Noa, Zhai, Wanting, Jensen, Roxanne E., Mandelblatt, Jeanne, Kumka, Susan, Unawane, Rashmi, Graves, Kristi D., Vesole, David H, Siegel, David S, Potosky, Arnold L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176031/
https://www.ncbi.nlm.nih.gov/pubmed/35844688
http://dx.doi.org/10.1002/jha2.231
Descripción
Sumario:We evaluated changes in patient‐reported outcomes and cognitive function from pre‐ to 3–6 months post‐treatment among 42 newly diagnosed patients with multiple myeloma undergoing transplant with complete data using PROMIS‐29. There were statistically significant improvements in physical (p < .001) and mental health (p < .001) but not cognition from pre‐treatment to 3–6 month follow‐up. Similar results were seen within age or comorbidity strata. Patients with myeloma undergoing transplant experienced generally improved short‐term health outcomes with no significant declines in cognition.